VIEWS AND ANALYSIS, PHARMACY MARKET

How to optimize clinical supply chain management with Slope

December 15, 2022

How to optimize
Successful execution of clinical trials requires the orchestration of multiple moving parts, with everything from protocol design and patient visit schedules, to lab kits and
biological samples needing to seamlessly line up to ensure on-time, on-budget delivery of high-quality data.

Spotlight

Young Innovators of Medicines

The Young Innovators of Medicines form the youth branch of the Innovative Medicines Association. This is a trade association for 44 drug companies with a Dutch branch. The youth branch was founded in 2013, under the then name Jong Nefarma. The members of the Association have put forward 22 high potentials to participate in the youth department. In recent years, young people themselves have defined themes such as talent and development, partnership with other young (care) associations, connecting young people within the Association, and debate and advice on important topics in the pharmaceutical industry.

OTHER WHITEPAPERS
news image

Nanoform Management Presentation

whitePaper | May 24, 2022

Our proprietary nanoforming technologies and services span the full range of drug development from small-molecule nanoparticles to large-molecule biologics.

Read More
news image

How purpose-built tech can help pharmaceutical and life science companies streamline healthcare provider interactions

whitePaper | December 15, 2022

In today’s hypercompetitive pharmaceutical and life sciences (PLS) industry, strategic partnerships are more critical than ever. A smaller life sciences company may have relationships with hundreds of healthcare providers and healthcare organizations.

Read More
news image

How to Choose the Right Contract Manufacturing Organisation for Your Pharmaceutical Product

whitePaper | November 21, 2022

Contract manufacturing can enhance the drug development process by creating effective processes, increasing manufacturing efficiencies, and reducing overhead costs.

Read More
news image

The Next Generation of Rare Disease Drug Policy

whitePaper | April 7, 2022

The United States defines a rare disease as a condition affecting fewer than 200,000 people in the country or one in which “there is no reasonable expectation” of recovering research and development costs.1 Examples of rare diseases include genetically-linked cancers, cystic fibrosis, and debilitating pediatric conditions like Gaucher disease and spinal muscular atrophy

Read More
news image

How Specialty Pharmacy Can Drive Better Outcomesin Multiple Sclerosis

whitePaper | June 14, 2022

Multiple sclerosis (MS) is a chronic, inflammatory disease of the central nervous system. Characterized by demyelination and neurodegeneration that affects the communication between the brain and other parts of the body, MS leads to physical and cognitive disability.

Read More
news image

DEVELOPING AND OPTIMIZING CLEANING PROCESSES

whitePaper | November 1, 2022

Equipment cleaning in manufacturing companies is often not given the same emphasis as other processes. It can be viewed as a task.

Read More

Spotlight

Young Innovators of Medicines

The Young Innovators of Medicines form the youth branch of the Innovative Medicines Association. This is a trade association for 44 drug companies with a Dutch branch. The youth branch was founded in 2013, under the then name Jong Nefarma. The members of the Association have put forward 22 high potentials to participate in the youth department. In recent years, young people themselves have defined themes such as talent and development, partnership with other young (care) associations, connecting young people within the Association, and debate and advice on important topics in the pharmaceutical industry.

Events